Astellas Completes Acquisition of Propella Therapeutics ...Middle East

PR Newswire - News
Astellas Completes Acquisition of Propella Therapeutics
TOKYO, Dec. 21, 2023 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") announced today that it has completed the acquisition of Propella Therapeutics, Inc. (President and CEO: William Moore, "Propella"), and has become a wholly owned subsidiary...

Hence then, the article about astellas completes acquisition of propella therapeutics was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Astellas Completes Acquisition of Propella Therapeutics )

Apple Storegoogle play

Last updated :

Also on site :